For investors seeking momentum, Barron's 400 ETF (BFOR - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 27% from its 52-week low price of $25.76/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
BFOR in Focus
BFOR focuses on high performing equity securities of U.S. companies. The underlying index of the fund normally comprises 400 stocks, which are selected on the basis of their fundamental strength in the yield of growth, value, profitability and cash flow.
BFOR charges investors 65 basis points a year in fees and has top holdings in Charles River Laboratories International, Home Depot and Intel (see Total Market (U.S.) ETFshere).
Why the Move?
With uncertainty prevailing in the market due to uneven U.S. economic growth, upheaval in oil prices and global growth issues, a look at a quality ETF like BFOR seems warranted at the current level.
More Gains Ahead?
The fund has a positive weighted alpha of 9.80. A positive weighted alpha hints at more gains.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, Barron's 400 ETF (BFOR - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 27% from its 52-week low price of $25.76/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
BFOR in Focus
BFOR focuses on high performing equity securities of U.S. companies. The underlying index of the fund normally comprises 400 stocks, which are selected on the basis of their fundamental strength in the yield of growth, value, profitability and cash flow.
BFOR charges investors 65 basis points a year in fees and has top holdings in Charles River Laboratories International, Home Depot and Intel (see Total Market (U.S.) ETFshere).
Why the Move?
With uncertainty prevailing in the market due to uneven U.S. economic growth, upheaval in oil prices and global growth issues, a look at a quality ETF like BFOR seems warranted at the current level.
More Gains Ahead?
The fund has a positive weighted alpha of 9.80. A positive weighted alpha hints at more gains.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BFOR - FREE